EP4413976
Ný vamórólón-samsetning sem sýnir bættan leysanleika
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
7.2.2023EP published:
13.8.2025EP application number:
23155431.2
EP translation filed:
27.8.2025Grant published:
15.9.2025EPO information:
European Patent Register
Max expiry date:
6.2.2043Expiry date:
6.2.2027Next due date:
28.2.2027
Title in English:
A NEW VAMOROLONE PREPARATION EXHIBITING IMPROVED SOLUBILITYLanguage of the patent:
English
Timeline
Today
7.2.2023EP application
13.8.2025EP Publication
27.8.2025Translation submitted
15.9.2025Registration published
6.2.2027Expires
Owner
Name:
Santhera Pharmaceuticals (Schweiz) AGAddress:
Hohenrainstrasse 24, 4133 Pratteln, CH
Inventor
Name:
ALLIERI, BrigidaAddress:
37138 Verona, IT
Name:
CHALLIS, BradleyAddress:
Nottingham, NG10 2BJ, GB
Name:
CHOPRA, ReenuAddress:
Nottingham, NG12 4HX, GB
Name:
DIAZ, LilianaAddress:
4125 Riehen, CH
Name:
HAUSMANN, RudolfAddress:
4052 Basel, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Classification
Categories:
A61K 9/14, A61K 9/16, A61K 31/5685, A61K 31/573, A61K 9/20
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 18.2.2026
Expires: 6.2.2027
Payer: Árnason Faktor ehf.